Procter & Gamble acquires consumer health business of Merck KGaA
Client(s) Procter & Gamble Company, The
Jones Day advised The Procter & Gamble Company (“P&G”) in its €3.4 billion ($4.2 billion) acquisition of the worldwide consumer health business of Merck KGaA. The consumer health business acquired is active across 44 countries and includes such strategic brands as Neurobion, Femibion, Nasivin, Bion3, and Seven Seas.